India to United States: Sertraline Export Trade Route
India has recorded 779 verified shipments of Sertraline exported to United States, representing a combined trade value of $329.0M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $422.3K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 91% of total export value with 405 shipments worth $299.3M USD. On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer in United States with $289.4M USD in purchases. The top 3 suppliers — CIPLA LIMITED, APL HEALTHCARE LIMITED, GRANULES INDIA LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Sertraline corridor is one of India's established pharmaceutical export routes, with 779 shipments documented worth a combined $329.0M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 91% of all export value, reflecting the consolidated nature of India's sertraline manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $422.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with sertraline's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 32.1%, placing it at rank #18 among India's top sertraline export destinations globally.
On the import side, key buyers of Indian sertraline in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, AUROBINDO PHARMA USA INC and 32 others. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the single largest importer with 258 shipments valued at $289.4M USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#18
- Annual growth+32.1%
- Demand growth+28.6%
- Regulatory ease87/100
Top 10 Indian Sertraline Exporters to United States
Showing top 10 of 11 Indian suppliers exporting Sertraline to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $739.0K per shipment | 405 | $299.3M | 91.0% |
| 2 | APL HEALTHCARE LIMITED Avg $112.8K per shipment | 115 | $13.0M | 3.9% |
| 3 | GRANULES INDIA LIMITED Avg $58.6K per shipment | 149 | $8.7M | 2.7% |
| 4 | LUPIN LIMITED Avg $147.6K per shipment | 25 | $3.7M | 1.1% |
| 5 | AUROBINDO PHARMA LTD Avg $57.9K per shipment | 34 | $2.0M | 0.6% |
| 6 | AUROBINDO PHARMA LIMITED Avg $49.1K per shipment | 18 | $883.7K | 0.3% |
| 7 | SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED Avg $48.0K per shipment | 18 | $864.9K | 0.3% |
| 8 | SIDMAK LABORATORIES INDIA PRIVATE LIMITED Avg $58.9K per shipment | 5 | $294.4K | 0.1% |
| 9 | SIDMAK LABORATORIES INDIA PVT LTD Avg $27.6K per shipment | 8 | $220.8K | 0.1% |
| 10 | EMCURE PHARMACEUTICALS LIMITED Avg $58.0K per shipment | 1 | $58.0K | 0.0% |
This table shows the top 10 of 11 Indian companies exporting sertraline to United States, ranked by total trade value. The listed exporters are: CIPLA LIMITED, APL HEALTHCARE LIMITED, GRANULES INDIA LIMITED, LUPIN LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, SIDMAK LABORATORIES INDIA PRIVATE LIMITED, SIDMAK LABORATORIES INDIA PVT LTD, EMCURE PHARMACEUTICALS LIMITED. CIPLA LIMITED is the dominant supplier with 405 shipments worth $299.3M USD, giving it a 91% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to United States Sertraline export route.
Top 10 Sertraline Importers in United States
Showing top 10 of 35 known buyers in United States receiving Sertraline shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sertraline in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, AUROBINDO PHARMA USA INC, XXROBXXDO XXARMXXUSAXX INXX, GRANULES PHARMACEUTICALS INC, among 35 total buyers. The largest importer is CIPLA USA INC UPS SUPPLY CHAIN SOLU, accounting for $289.4M USD across 258 shipments — representing 88% of all sertraline imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 258 | $289.4M | 88.0% |
| 2 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 111 | $8.2M | 2.5% |
| 3 | AUROBINDO PHARMA USA INC | 17 | $5.1M | 1.6% |
| 4 | XXROBXXDO XXARMXXUSAXX INXX | 21 | $3.5M | 1.1% |
| 5 | GRANULES PHARMACEUTICALS INC | 50 | $3.4M | 1.0% |
| 6 | GRANULES PHARMACEUTICALS, INC | 59 | $2.9M | 0.9% |
| 7 | GRANULES PHARMACEUTICALS, INC. | 40 | $2.5M | 0.8% |
| 8 | Lupin Pharmaceutical Inc | 14 | $2.2M | 0.7% |
| 9 | NORTHSTAR HEALTHCARE | 26 | $2.0M | 0.6% |
| 10 | XXPINXXHARXXCEUXXCALXXINC | 8 | $1.2M | 0.4% |
Showing top 10 of 35 Sertraline importers in United States on this route.
Top 10 Sertraline Formulations Imported by United States
Showing top 10 of 368 product formulations shipped on the India to United States Sertraline route, ranked by trade value
United States imports a wide range of sertraline formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SERTRALINE TABLETS, USP 50 MG; NDC NO.69097-834-12; ANDA NO.:077397 PACK SIZE1 X 500S — accounts for $122.9M USD across 3 shipments. There are 368 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SERTRALINE TABLETS, USP 50 MG; NDC NO.69097-834-12; ANDA NO.:077397 PACK SIZE1 X 500S | 3 | $122.9M | 37.3% |
| 2 | SERTRALINE TABLETS, USP 50 MG; NDC NO.:69097-834-12; ANDA NO.:077397 PACK SIZE1 X 500S | 1 | $41.3M | 12.6% |
| 3 | SERTRALINE TABLETS, USP 50 MG NDC NO.69097-834-12 ANDA NO.077397 (9336 PACKSX 1X500S=4668000 NOS) | 1 | $40.7M | 12.4% |
| 4 | SERTRALINE TABLETS, USP 50 MG NDC NO.69097-834-12 ANDA NO.077397 (9240 PACKSX 1X500S=4620000 NOS) | 1 | $40.3M | 12.2% |
| 5 | SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397 (INV.QTY.9600 PACK 1X500S=4800000 NOS) | 1 | $21.8M | 6.6% |
| 6 | SERTRALINE TABLETS, USP 25 MG NDC NO.69097-833-05 ANDA NO. 077397 . (INV.QTY.86040 PACK 1X90S=7743600 NOS) | 1 | $7.4M | 2.2% |
| 7 | SERTRALINE HYDROCHLORIDE TABLETS 100MG | 60 | $5.7M | 1.7% |
| 8 | SERTRALINE HYDROCHLORIDE TABLETS 50MG | 37 | $4.1M | 1.3% |
| 9 | SERTRALINE HYDROCHLORIDE TABLETS 25MG | 18 | $3.2M | 1.0% |
| 10 | SERTRALINE TABLETS,USP 25 MG;NDC NO.:69097-833-05;ANDA NO.:077397(PACK SIZE:1X90X18600=1674000 NOS) | 1 | $1.6M | 0.5% |
Showing top 10 of 368 Sertraline formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 134 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's sertraline exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 405 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, APL HEALTHCARE LIMITED, GRANULES INDIA LIMITED — together account for 98% of total trade value on this route. The average shipment value of $422.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as sertraline tablets, usp 50 mg; ndc no.:69097-834-12; anda no.:077397 pack size1 x 500s and sertraline tablets, usp 50 mg ndc no.69097-834-12 anda no.077397 (9336 packsx 1x500s=4668000 nos), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer with 258 shipments worth $289.4M USD — representing 88% of all sertraline imports from India on this route. A total of 35 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $329.0M
- Avg. Shipment
- $422.3K
- Suppliers
- 11
- Buyers
- 35
- Transit (Sea)
- ~15 days
- Annual Growth
- +32.1%
Related Analysis
Reverse Direction
United States → India — Sertraline (Import)Other Sertraline Routes
Unlock the Full India to United States Sertraline Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 779 shipments on this route.
Frequently Asked Questions — India to United States Sertraline Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sertraline to United States?
The leading Indian exporters of Sertraline to United States are CIPLA LIMITED, APL HEALTHCARE LIMITED, GRANULES INDIA LIMITED. CIPLA LIMITED holds the largest market share at approximately 91% of total trade value on this route.
Q What is the total value of Sertraline exports from India to United States?
India exports Sertraline to United States worth approximately $329.0M USD across 779 recorded shipments. The average value per shipment is $422.3K USD.
Q Which ports does India use to ship Sertraline to United States?
The most active port of origin is SAHAR AIR with 134 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Sertraline?
The average transit time for Sertraline shipments from India to United States is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Sertraline trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.1% with demand growth tracking at 28.6%. The route is ranked #18 among India's top Sertraline export destinations globally.
Q How many suppliers are active on the India to United States Sertraline route?
There are currently 11 active Indian suppliers exporting Sertraline to United States. The market is moderately concentrated with CIPLA LIMITED accounting for 91% of total shipment value.
Q Who are the main importers of Sertraline from India in United States?
The leading importers of Indian Sertraline in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, AUROBINDO PHARMA USA INC, XXROBXXDO XXARMXXUSAXX INXX, GRANULES PHARMACEUTICALS INC. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer with 258 shipments worth $289.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Sertraline.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 35 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 779 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
779 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists